• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VolitionRX Ltd

+ Add to Watchlist


2.6000 USD 0.2000 8.33%

As of 20:10:00 ET on 04/17/2014.

Snapshot for VolitionRX Ltd (VNRX)

Open: 2.5000 Day's Range: 2.5000 - 2.6000 Volume: 2,220
Previous Close: 2.4000 52wk Range: 0.2500 - 3.2500 1-Yr Rtn: -1.89%

Stock Chart for VNRX

No chart data available.
  • VNRX:US 2.6000
  • 1D
  • 1M
  • 1Y
Interactive VNRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 34.60
Shares Outstanding (M) 13.31
30 Day Average Volume 4,605
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNRX

No data available

Company Profile & Key Executives for VNRX

Volition RX Ltd manufactures epigenetic cancer detection blood tests. The Company's tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types.

Martin C FaulkesChairmanCameron ReynoldsPresident/CEO
Malcolm T LewinCFO/TreasurerThomas BygottDirector:Sales & Marketing
More Company Profile & Key Executives for VNRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil